Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
How to watch the ‘Wicked: One Wonderful Night’ special — now streaming - 2Best Quest for new employment Site for You to Track down Amazing open doors
- 3Thousands of small fish defy gravity to climb Congo waterfall
- 4The 15 Best Business visionaries Under 40
- 5Army commander convicted of Guinea stadium massacre dies in prison
- Artemis 2 astronauts head for the moon after make-or-break engine burn (video)
- From Novice to Master: Dominating a Side interest
- 6 Famous Urban communities for Shopping on the planet
- NASA's giant moon rocket, in photos
- South Korea president says Iran war shows the need to ditch ‘extremely risky’ fossil fuels
- Violence 'never part' of break-in plan, court told
- The best movies to watch this holiday season: Stream 'A Christmas Story Christmas,' revisit 'The Night Before' and discover 'The Baltimorons'
- EU-funded BioSupPack project turns brewery waste into bioplastics
- The Most Moving TED Talks You Want to Watch
